Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1990 1
1991 1
1994 1
1997 5
1998 4
2005 1
2006 1
2007 1
2008 1
2009 2
2010 9
2011 9
2012 9
2013 2
2014 4
2015 5
2016 5
2017 5
2018 7
2019 5
2020 12
2021 8
2022 9
Text availability
Article attribute
Article type
Publication date

Search Results

100 results
Results by year
Filters applied: . Clear all
Page 1
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study.
D'Alessio A, Fulgenzi CAM, Nishida N, Schönlein M, von Felden J, Schulze K, Wege H, Gaillard VE, Saeed A, Wietharn B, Hildebrand H, Wu L, Ang C, Marron TU, Weinmann A, Galle PR, Bettinger D, Bengsch B, Vogel A, Balcar L, Scheiner B, Lee PC, Huang YH, Amara S, Muzaffar M, Naqash AR, Cammarota A, Personeni N, Pressiani T, Sharma R, Pinter M, Cortellini A, Kudo M, Rimassa L, Pinato DJ. D'Alessio A, et al. Among authors: muzaffar m. Hepatology. 2022 Oct;76(4):1000-1012. doi: 10.1002/hep.32468. Epub 2022 Apr 8. Hepatology. 2022. PMID: 35313048
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma.
Muhammed A, Fulgenzi CAM, Dharmapuri S, Pinter M, Balcar L, Scheiner B, Marron TU, Jun T, Saeed A, Hildebrand H, Muzaffar M, Navaid M, Naqash AR, Gampa A, Ozbek U, Lin JY, Perone Y, Vincenzi B, Silletta M, Pillai A, Wang Y, Khan U, Huang YH, Bettinger D, Abugabal YI, Kaseb A, Pressiani T, Personeni N, Rimassa L, Nishida N, Di Tommaso L, Kudo M, Vogel A, Mauri FA, Cortellini A, Sharma R, D'Alessio A, Ang C, Pinato DJ. Muhammed A, et al. Among authors: muzaffar m. Cancers (Basel). 2021 Dec 31;14(1):186. doi: 10.3390/cancers14010186. Cancers (Basel). 2021. PMID: 35008350 Free PMC article.
Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer.
Macherla S, Laks S, Naqash AR, Bulumulle A, Zervos E, Muzaffar M. Macherla S, et al. Among authors: muzaffar m. Int J Mol Sci. 2018 Nov 7;19(11):3505. doi: 10.3390/ijms19113505. Int J Mol Sci. 2018. PMID: 30405053 Free PMC article. Review.
Role of sacituzumab govitecan in solid tumors.
Veeraballi S, Khawar Z, Aslam HM, Muzaffar M. Veeraballi S, et al. Among authors: muzaffar m. J Oncol Pharm Pract. 2022 Oct;28(7):1617-1623. doi: 10.1177/10781552221092359. Epub 2022 Apr 11. J Oncol Pharm Pract. 2022. PMID: 35404158 Review.
Eribulin-Associated Foot Drop.
Blair TF, Lambert K, Muzaffar M. Blair TF, et al. Among authors: muzaffar m. Am J Ther. 2019 Nov/Dec;26(6):e720-e722. doi: 10.1097/MJT.0000000000000881. Am J Ther. 2019. PMID: 30570505 No abstract available.
Water and sanitation risk exposure in children under-five in Pakistan.
Murtaza F, Muzaffar M, Mustafa T, Anwer J. Murtaza F, et al. Among authors: muzaffar m. J Family Community Med. 2021 May-Aug;28(2):103-109. doi: 10.4103/jfcm.jfcm_149_21. Epub 2021 May 8. J Family Community Med. 2021. PMID: 34194274 Free PMC article.
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study.
Marinelli B, Kim E, D'Alessio A, Cedillo M, Sinha I, Debnath N, Kudo M, Nishida N, Saeed A, Hildebrand H, Kaseb AO, Abugabal YI, Pillai A, Huang YH, Khan U, Muzaffar M, Naqash AR, Patel R, Fischman A, Bishay V, Bettinger D, Sung M, Ang C, Schwartz M, Pinato DJ, Marron T. Marinelli B, et al. Among authors: muzaffar m. J Immunother Cancer. 2022 Jun;10(6):e004205. doi: 10.1136/jitc-2021-004205. J Immunother Cancer. 2022. PMID: 35710293 Free PMC article.
100 results